In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
United States | 321.9 | 310.7 | 336.1 | | 332.3 | | 220.2 | 232.1 |
Europe | | | | | 43.2 | | 63.1 | 56.8 |
Latin America | | | | | 13.5 | | 14.9 | |
Canada | 7.6 | 7.0 | 7.0 | | 9.3 | | 13.7 | 13.5 |
Other | 37.5 | 38.3 | 45.5 | | 5.3 | | | 26.8 |
Total revenues [+] | 367.0 | 356.0 | 388.6 | 419.5 | 403.5 | 399.5 | 270.8 | 329.2 |
Royalties | | | | | | | | 60.4 |
Services | | | | | | | 270.8 | 329.2 |
Revenue growth [+] | 3.1% | -8.4% | -7.4% | 3.9% | 1.0% | 47.5% | -17.7% | 14.7% |
United States | 3.6% | -7.5% | | | | | -5.1% | 14.5% |
Europe | | | | | | | 11.1% | 14.7% |
Canada | 8.3% | 0.0% | | | | | 1.1% | 6.9% |
Other | | | | | | | -73.0% | 21.7% |
Cost of goods sold | 203.0 | 180.7 | 199.6 | 200.2 | 193.6 | 173.1 | 111.9 | 97.5 |
Gross profit | 164.0 | 175.3 | 189.0 | 219.3 | 209.9 | 226.4 | 158.9 | 231.7 |
Gross margin | 44.7% | 49.2% | 48.6% | 52.3% | 52.0% | 56.7% | 58.7% | 70.4% |
Selling, general and administrative [+] | 128.7 | 126.0 | 155.6 | 192.9 | 205.2 | 223.8 | 168.8 | 166.4 |
Sales and marketing | 66.9 | 70.2 | 89.1 | 108.4 | 130.5 | 126.3 | 96.3 | 103.5 |
General and administrative | 61.7 | 55.8 | 66.4 | 84.5 | 74.7 | 97.5 | 72.5 | 62.9 |
Research and development | 39.1 | 38.7 | 61.8 | 77.0 | 89.0 | 87.0 | 52.7 | 60.4 |
Other operating expenses | | 4.7 | 4.3 | 38.3 | 83.4 | 78.5 | 8.6 | |
EBITDA [+] | 12.0 | 20.0 | -19.9 | -71.7 | -144.3 | -105.6 | -40.1 | 22.9 |
EBITDA growth | -40.2% | -200.7% | -72.3% | -50.3% | 36.6% | 163.6% | -275.3% | -12.9% |
EBITDA margin | 3.3% | 5.6% | -5.1% | -17.1% | -35.8% | -26.4% | -14.8% | 6.9% |
Depreciation | 15.8 | 14.1 | 12.8 | 17.3 | 23.3 | 25.4 | 22.6 | 18.0 |
EBITA | -3.8 | 5.9 | -32.6 | -89.0 | -167.6 | -131.0 | -62.7 | 4.9 |
EBITA margin | -1.0% | 1.7% | -8.4% | -21.2% | -41.5% | -32.8% | -23.1% | 1.5% |
Amortization of intangibles | 25.0 | 27.2 | 30.1 | 32.9 | 34.8 | 31.9 | 8.6 | 7.2 |
EBIT [+] | -28.9 | -21.3 | -62.7 | -121.8 | -202.5 | -162.9 | -71.3 | -2.4 |
EBIT growth | 35.7% | -66.1% | -48.5% | -39.8% | 24.3% | 128.6% | 2922.2% | -255.2% |
EBIT margin | -7.9% | -6.0% | -16.1% | -29.0% | -50.2% | -40.8% | -26.3% | -0.7% |
Non-recurring items [+] | | | 247.7 | 17.1 | 93.0 | -31.1 | 3.8 | 12.4 |
Asset impairment | | | 241.6 | | | | | 9.7 |
Loss (gain) on sale of assets | | | | | | -33.5 | 4.7 | |
Legal settlement | | | 2.9 | 5.3 | 82.5 | 2.4 | -0.8 | 2.7 |
Interest expense | 7.8 | 35.8 | 31.5 | 16.5 | 0.7 | 0.5 | 1.3 | |
Interest expense | 7.8 | 35.8 | 31.5 | 16.5 | 0.7 | 0.5 | 1.3 | |
Other income (expense), net [+] | -12.5 | 10.1 | 2.0 | -0.2 | 12.1 | 11.1 | -1.3 | -0.4 |
Gain (loss) on debt retirement | -9.6 | | | | | | | |
Gain (loss) on foreign currency transactions | 2.9 | -4.5 | 0.3 | 1.3 | -3.2 | -1.2 | -1.3 | 0.8 |
Other | -5.8 | 14.6 | 1.7 | -1.5 | 15.2 | 12.4 | 0.0 | -1.2 |
Pre-tax income | -49.2 | -47.0 | -340.0 | -155.6 | -284.1 | -121.2 | -77.7 | -15.2 |
Income taxes | 0.9 | 0.9 | -1.0 | 3.7 | -2.7 | -4.0 | 0.5 | -5.3 |
Tax rate | | | 0.3% | | 1.0% | 3.3% | | 34.9% |
Net income | -62.7 | -47.9 | -339.0 | -159.3 | -281.4 | -117.2 | -78.2 | -9.9 |
Net margin | -17.1% | -13.5% | -87.2% | -38.0% | -69.7% | -29.3% | -28.9% | -3.0% |
|
Basic EPS [+] | ($0.78) | ($0.67) | ($5.33) | ($2.76) | ($4.90) | ($2.10) | ($2.07) | ($0.29) |
Growth | 15.2% | -87.4% | 93.1% | -43.6% | 132.8% | 1.8% | 602.5% | 334.0% |
Diluted EPS [+] | ($0.78) | ($0.67) | ($5.33) | ($2.76) | ($4.90) | ($2.10) | ($2.07) | ($0.29) |
Growth | 15.2% | -87.4% | 93.1% | -43.6% | 132.8% | 1.8% | 602.5% | 334.0% |
|
Shares outstanding (basic) [+] | 80.8 | 71.2 | 63.6 | 57.7 | 57.5 | 55.7 | 37.9 | 33.7 |
Growth | 13.5% | 11.9% | 10.2% | 0.4% | 3.2% | 47.1% | 12.4% | -2.2% |
Shares outstanding (diluted) [+] | 80.8 | 71.2 | 63.6 | 57.7 | 57.5 | 55.7 | 37.9 | 33.7 |
Growth | 13.5% | 11.9% | 10.2% | 0.4% | 3.2% | 47.1% | 12.4% | -2.2% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |